Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > Clinical Trials To Begin For Sona Nanotech’s COVID-19 Rapid

<< Previous

Bullboard Posts

Next >>

Comment by Kaiseron Jun 15, 2021 2:13pm

133 Views

Post# 33389448

RE:RE:Clinical Trials To Begin For Sona Nanotech’s COVID-19 Rapid

Definitely... wrong! Lol only thing that's a guarantee is that you're a no knowledge pumper.

Moemoney42 wrote:

AwareInvestor wrote:
Sona Nanotech Inc. announced after market close last night that it has received the go signal from the research ethics board to proceed with the previously approved clinical trials for its saliva-based COVID-19 rapid antigen test. The trials are expected to begin next week.

https://thedeepdive.ca/clinical-trials-to-begin-for-sona-nanotechs-covid-19-rapid-saliva-test/

This news although long overdue is great and should propel the stock over $2 today..One would hope that the long development time line has given SONA the ability to fine tune the test so that its nearly guaranteed approval... could be good news by the end of the month... if not, definately next month... ;-)